Bicycle Therapeutics Enhances Board of Directors
Appoints pharmaceutical industry veteran Richard N. Kender, MBA, and life sciences financing professional Janice Bourque, MBA Orderly transition planned for…
Pharmaceuticals, Biotechnology and Life Sciences
Appoints pharmaceutical industry veteran Richard N. Kender, MBA, and life sciences financing professional Janice Bourque, MBA Orderly transition planned for…
— Financing proceeds to advance ArunA Bio’s neural exosome therapies for neurodegenerative diseases and partnering activities — — ArunA Bio…
Second-quarter revenue $2,740 million Adjusted EBITDA $578 million GAAP Diluted Earnings per Share $0.30; Adjusted Diluted Earnings per Share $1.53…
2Q19 total revenues of $1,203.3 million, a 15 percent increase over 2Q18 and a 23 percent volume increase 2Q19 GAAP…
DUBLIN–(BUSINESS WIRE)–ICON plc (NASDAQ: ICLR), a global provider of drug development solutions and services to the pharmaceutical, biotechnology and medical…
BOTHELL, Wash.–(BUSINESS WIRE)–Seattle Genetics, Inc. (Nasdaq: SGEN) today announced the pricing of an underwritten public offering of 7,142,858 shares of…
NEW YORK–(BUSINESS WIRE)–Pfizer Inc. (NYSE:PFE) today announced the United States (U.S.) Food and Drug Administration (FDA) has approved RUXIENCE™ (rituximab-pvvr),…
DUBLIN–(BUSINESS WIRE)–The “Scientific Research & Development Services Global Market Report 2019” report has been added to ResearchAndMarkets.com’s offering. Scientific Research…
An in silico clinical trial is underway with the 3DEXPERIENCE platform to evaluate the Living Heart simulated 3D heart for…